Literature DB >> 19327406

Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?

Nancy Garbacki1, Emmanuel Di Valentin, Jacques Piette, Didier Cataldo, Céline Crahay, Alain Colige.   

Abstract

Among the large matrix metalloproteinases (MMPs) family, MMP-12, also referred to as macrophage elastase, plays a significant role in chronic pulmonary pathologies characterized by an intense tissue remodeling such as asthma and COPD. This review will summarize knowledge about MMP-12 structure, functions and mechanisms of activation and regulation, including potential MMP-12 modulation by microRNA. As MMP-12 is involved in many tissue remodeling diseases, efforts have been made to develop specific synthetic inhibitors. However, at this time, very few chemical inhibitors have proved to be efficient and specific to a particular MMP. The relevance of silencing MMP-12 by RNA interference is highlighted. The specificity of this approach using siRNA or shRNA and the strategies to deliver these molecules in the lung are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327406     DOI: 10.1016/j.pupt.2009.03.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  12 in total

Review 1.  The emerging role of microRNAs in asthma.

Authors:  Xiaoying Jiang
Journal:  Mol Cell Biochem       Date:  2011-03-06       Impact factor: 3.396

2.  Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients.

Authors:  Wendong Hao; Manxiang Li; Yunqing Zhang; Cailian Zhang; Ping Wang
Journal:  Lung       Date:  2019-08-26       Impact factor: 2.584

3.  First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.

Authors:  Khalid Abd-Elaziz; Christine Voors-Pette; Kang-Ling Wang; Sandy Pan; Yisheng Lee; John Mao; Yuhua Li; Benjamin Chien; David Lau; Zuzana Diamant
Journal:  Clin Drug Investig       Date:  2020-12-17       Impact factor: 2.859

Review 4.  Diverse functions of matrix metalloproteinases during fibrosis.

Authors:  Matthew Giannandrea; William C Parks
Journal:  Dis Model Mech       Date:  2014-02       Impact factor: 5.758

Review 5.  [Research Progress of Biomakers Proteomics-based in Lung Cancer].

Authors:  Hui Xie; Zhengang Chen; Guangshun Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

6.  The role of MMP-12 gene polymorphism - 82 A-to-G (rs2276109) in immunopathology of COPD in polish patients: a case control study.

Authors:  Iwona Gilowska; Edyta Majorczyk; Łukasz Kasper; Katarzyna Bogacz; Jan Szczegielniak; Marta Kasper; Jacek Kaczmarski; Aleksandra Skomudek; Marcin Czerwinski; Krzysztof Sładek
Journal:  BMC Med Genet       Date:  2019-01-18       Impact factor: 2.103

7.  MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis.

Authors:  Lukasz Stawski; Paul Haines; Alan Fine; Lidia Rudnicka; Maria Trojanowska
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

8.  Extracellular microRNA-21 and microRNA-26a increase in body fluids from rats with antigen induced pulmonary inflammation and children with recurrent wheezing.

Authors:  Congshan Jiang; Hongchuan Yu; Qingzhu Sun; Wenhua Zhu; Jing Xu; Ning Gao; Rui Zhang; Li Liu; Xiaoying Wu; Xudong Yang; Liesu Meng; Shemin Lu
Journal:  BMC Pulm Med       Date:  2016-04-14       Impact factor: 3.317

9.  Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice.

Authors:  Hyeon-Young Kim; Min-Seok Kim; Sung-Hwan Kim; Doin Joen; Kyuhong Lee
Journal:  Molecules       Date:  2018-08-07       Impact factor: 4.411

10.  Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.

Authors:  Jamie L Todd; Richard Vinisko; Yi Liu; Megan L Neely; Robert Overton; Kevin R Flaherty; Imre Noth; L Kristin Newby; Joseph A Lasky; Mitchell A Olman; Christian Hesslinger; Thomas B Leonard; Scott M Palmer; John A Belperio
Journal:  BMC Pulm Med       Date:  2020-03-14       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.